Ninth Asia Pacific League of Associations for Rheumatology (APLAR) Congress, Beijing, China, 21-26 May, 2000

D Barraclough1,

  • 1Rheumatology Unit, Royal Melbourne Hospital, Parkville, Victoria, Australia.

Arthritis Research
|February 24, 2001
PubMed

Insights

This rheumatology congress highlighted inflammatory cytokines and addressed atherosclerosis in rheumatic diseases. Discussions included regional conditions like Behcet's and Takayasu's diseases, alongside advancements in therapies.

Area of Science:

  • Rheumatology
  • Immunology
  • Cardiovascular Science

Background:

  • The congress convened global rheumatology experts, focusing on inflammatory cytokines and their role in rheumatic diseases.
  • Key regional diseases such as Behcet's disease and Takayasu's disease were extensively discussed.
  • Atherosclerosis in the context of rheumatic diseases was a significant topic.

Framework:

  • The scientific program featured plenary lectures, symposia, workshops, and free paper sessions.
  • Basic science research, particularly on inflammatory cytokines, was well-represented.
  • Presentations covered a wide spectrum of rheumatological conditions and research areas.

Implementation:

  • Symposia explored the latest pharmacological advances, including COX-2 inhibitors, leflunomide, and anti-tumour necrosis factor (TNF) therapy.
  • Despite cost restrictions in the Asia Pacific League of Associations of Rheumatology (APLAR) region, recent drug developments were a focus.
  • Management of spondyloarthritis and musculoskeletal infections in HIV-positive patients were also key discussion points.

Implications:

  • The congress facilitated knowledge exchange on inflammatory cytokines and their impact on rheumatic diseases.
  • It highlighted the need for accessible advanced therapies in regions like APLAR.
  • The event underscored the interconnectedness of rheumatology, immunology, and cardiovascular health.

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...